{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:48:55Z","timestamp":1774363735566,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.prp.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T18:30:19Z","timestamp":1477420219000},"page":"79-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Histomorphological changes in endometriosis in a patient treated with ulipristal: A case report"],"prefix":"10.1016","volume":"213","author":[{"given":"J.","family":"Bateman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Bougie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2016.10.010_bib0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2016.10.010_bib0010","unstructured":"Fibristal Health Canada website. March 24, 2015. Available at: http:\/\/www.hc-sc.gc.ca\/dhp-mps\/prodpharma\/sbd-smd\/drug-med\/sbd smd 2013 fibristal 156861-eng.php#al (accessed 05.10.16)."},{"key":"10.1016\/j.prp.2016.10.010_bib0015","first-page":"4","article-title":"Selective progesterone receptor modulators: clinical roles and effects on endometrial histology","volume":"2015","author":"Latta","year":"2015","journal-title":"Can. J. Pathol., Suppl. 2, Winter"},{"issue":"5","key":"10.1016\/j.prp.2016.10.010_bib0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2016.10.010_bib0025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2016.10.010_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ogc.2014.10.005","article-title":"Current strategies for endometriosis management","volume":"42","author":"Kodaman","year":"2015","journal-title":"Obstetrics Gynecol. Clin. N. Am."},{"key":"10.1016\/j.prp.2016.10.010_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/461024","article-title":"Identification of susceptibility genes for peritoneal, ovarian: and deep infiltrating endometriosis using a pooled sample-based genome-wide association study","volume":"2015","author":"Borghese","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"4","key":"10.1016\/j.prp.2016.10.010_bib0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/GCO.0000000000000082","article-title":"Selective progesterone receptor modulators","volume":"26","author":"Whitaker","year":"2014","journal-title":"Curr. Opin. Obstetrics Gynecol."},{"issue":"2","key":"10.1016\/j.prp.2016.10.010_bib0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejogrb.2013.03.022","article-title":"The effects of ulipristal on Bax\/Bcl-2, cytochrome c, ki-67 and cyclooxygenase-2 expression in a rat model with surgically induced endometriosis","volume":"169","author":"Huniadi","year":"2013","journal-title":"Eur. J. Obstetrics, Gynecol., Reprod. Biol."},{"key":"10.1016\/j.prp.2016.10.010_bib0050","doi-asserted-by":"crossref","unstructured":"S. Bulun, Northwestern University, Phase IV pilot study of ulipristal acetate for treatment of endometriosis-related pelvic pain, In: ClinicalTrials.gov Internet. Bethesda (MD): National Library of Medicine (US). 2000- cited 2016 Oct 1. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02213081 NLM Identifier: NCT02213081.","DOI":"10.24966\/RMGO-2574\/100008"},{"key":"10.1016\/j.prp.2016.10.010_bib0055","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.4049\/jimmunol.1300958","article-title":"Uterine NK cells regulate endometrial bleeding in women and are suppressed by the progesterone receptor modulator asoprisnil","volume":"191","author":"Wilkens","year":"2013","journal-title":"J. Immunol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816302096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816302096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T08:06:39Z","timestamp":1657526799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033816302096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0344033816302096"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2016.10.010","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histomorphological changes in endometriosis in a patient treated with ulipristal: A case report","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}